Onkure Therapeutics Inc (OKUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -53,834 | -34,638 | -15,107 | -51,955 | -38,355 |
| Depreciation Amortization | -3,425 | -1,928 | -729 | -712 | -106 |
| Accounts payable and accrued liabilities | 6,507 | 6,690 | 3,398 | 518 | 2,838 |
| Other Working Capital | 8,138 | 7,949 | 5,213 | 959 | 3,646 |
| Other Operating Activity | -1,315 | -3,235 | -1,823 | 3,828 | 228 |
| Operating Cash Flow | $-43,929 | $-25,162 | $-9,048 | $-47,362 | $-31,749 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -29,058 | -50,327 | 18,679 | -57,496 | -30,829 |
| PPE Investments | -196 | -177 | -172 | -346 | -96 |
| Investing Cash Flow | $-29,254 | $-50,504 | $18,507 | $-57,842 | $-30,925 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 64,993 | 64,820 | 1,009 | 471 | 146 |
| Financing Cash Flow | $64,993 | $64,820 | $1,009 | $471 | $146 |
| Beginning Cash Position | 19,927 | 19,927 | 19,927 | 124,660 | 124,660 |
| End Cash Position | 11,737 | 9,081 | 30,395 | 19,927 | 62,132 |
| Net Cash Flow | $-8,190 | $-10,846 | $10,468 | $-104,733 | $-62,528 |
| Free Cash Flow | |||||
| Operating Cash Flow | -43,929 | -25,162 | -9,048 | -47,362 | -31,749 |
| Capital Expenditure | -196 | -177 | -172 | -346 | -96 |
| Free Cash Flow | -44,125 | -25,339 | -9,220 | -47,708 | -31,845 |